Paper352264
Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli.
Suter W and 2 others. Antimicrob Agents Chemother, 1978. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli. Papers, record 352264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/352264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Escherichia coli | Major topic |
| Quinoxalines | Major topic |
| Anaerobiosis | |
| Chloramphenicol | |
| DNA, Bacterial | |
| Drug Resistance, Microbial | |
| Macromolecular Substances | |
| Mutation | |
| Oxidation-Reduction |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4548053 | Letter: The yield of single-strand breaks in the DNA of bacteriophage lambda irradiated extra- and intracellularly with gamma-rays in oxic and anoxic conditions. | Int J Radiat Biol Relat Stud Phys Chem Med | 1974 | https://conductscience.org/library/papers/4548053 | PubMed |
| 2 | 4373040 | The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. | Biochemistry | 1974 | https://conductscience.org/library/papers/4373040 | PubMed |
| 3 | 4553051 | Antibacterial properties of quindoxin: a new growth-promoting agent. | Vet Rec | 1972 | https://conductscience.org/library/papers/4553051 | PubMed |
| 4 | 4553750 | Inhibition of ribonucleic acid synthesis by myxin. | Biochemistry | 1972 | https://conductscience.org/library/papers/4553750 | PubMed |
| 5 | 4556973 | Induction of phage formation in lysogenic Escherichia coli by myxin. | J Gen Microbiol | 1972 | https://conductscience.org/library/papers/4556973 | PubMed |
| 6 | 4568763 | Pedigrees of some mutant strains of Escherichia coli K-12. | Bacteriol Rev | 1972 | https://conductscience.org/library/papers/4568763 | PubMed |
| 7 | 4599989 | An endonuclease from Escherichia coli that acts preferentially on UV-irradiated DNA and is absent from the uvrA and uvrB mutants. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4599989 | PubMed |
| 8 | 4601366 | Some properties of mutants of Escherichia coli K12 defective in DNA polymerase I and exonuclease V. | Mol Gen Genet | 1974 | https://conductscience.org/library/papers/4601366 | PubMed |
| 9 | 4607624 | Isolation and characterization of an Escherichia coli K-12 mutant with a temperature-sensitive recA- phenotype. | J Bacteriol | 1974 | https://conductscience.org/library/papers/4607624 | PubMed |
| 10 | 4864404 | Mode of action of myxin on Escherichia coli. | J Bacteriol | 1967 | https://conductscience.org/library/papers/4864404 | PubMed |
| 11 | 4879097 | Studies on radiation-sensitive mutants of E. coli. I. Mutants defective in the repair synthesis. | Mol Gen Genet | 1968 | https://conductscience.org/library/papers/4879097 | PubMed |
| 12 | 4881840 | Lethal action and metabolic effects of streptonigrin on Escherichia coli. | Mol Pharmacol | 1968 | https://conductscience.org/library/papers/4881840 | PubMed |
| 13 | 4898990 | Characteristics of some multiply recombination-deficient strains of Escherichia coli. | J Bacteriol | 1969 | https://conductscience.org/library/papers/4898990 | PubMed |
| 14 | 4905190 | Effect of inhibitors of DNA synthesis of UV-sensitive derivatives of Escherichia coli strain K-12. | Mutat Res | 1970 | https://conductscience.org/library/papers/4905190 | PubMed |
| 15 | 4905567 | Quinoxaline-1, 4-di-N oxides. I. Inhibition of deoxyribonucleic acid synthesis in Escherichia coli by 2,3-dihydroxymethyl-quinoxaline-1, 4-di-N-oxide. | Proc Soc Exp Biol Med | 1970 | https://conductscience.org/library/papers/4905567 | PubMed |
| 16 | 4961479 | [Continuous recording of physico-chemical data in bacterial cultures. II. Influence of dissolved oxygen on the measurement of oxidation-reduction potentials in bacterial cultures]. | Z Allg Mikrobiol | 1965 | https://conductscience.org/library/papers/4961479 | PubMed |
| 17 | 4119484 | Action of bleomycin on DNA and RNA. | Eur J Biochem | 1972 | https://conductscience.org/library/papers/4119484 | PubMed |
| 18 | 5072575 | The growth promoting activity of quinoxaline-I, 4-dioxide (quindoxin) in young chicken (Gallus domesticus). | Res Vet Sci | 1972 | https://conductscience.org/library/papers/5072575 | PubMed |
| 19 | 5327367 | Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality. | J Bacteriol | 1966 | https://conductscience.org/library/papers/5327367 | PubMed |
| 20 | 5327370 | Mechanism of action of nalidixic acid on Escherichia coli. IV. Effects on the stability of cellular constituents. | J Bacteriol | 1966 | https://conductscience.org/library/papers/5327370 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42221845 | Synergistic Effects of Thymoquinone, 3-Hydrazinoquinoxaline-2-Thiol, and Amphotericin B Against Methicillin-Resistant Staphylococcus aureus: In vitro and in silico Evaluation. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42221845 | PubMed |
| 40791182 | Thymoquinone and 3HQ synergy inhibits CTX-M-15 ESBL. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40791182 | PubMed |
| 40332345 | A Quinoxaline 1,4-Dioxide Activates DNA Repair Systems in Mycobacterium smegmatis: A Transcriptomic Study. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332345 | PubMed |
| 40172295 | Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An in vitro and in silico evaluation. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40172295 | PubMed |
| 38283148 | Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity. | Front Genet | 2023 | https://conductscience.org/library/papers/38283148 | PubMed |
| 37631089 | Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37631089 | PubMed |
| 36620005 | Dietary supplementation of Bacillus subtilis or antibiotics modified intestinal microbiome of weaned pigs under enterotoxigenic Escherichia coli infection. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36620005 | PubMed |
| 35215268 | Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35215268 | PubMed |
| 33573321 | Metabolomic Profile of Weaned Pigs Challenged with E. coli and Supplemented with Carbadox or Bacillus subtilis. | Metabolites | 2021 | https://conductscience.org/library/papers/33573321 | PubMed |
| 33546407 | The Spectrum of Antimicrobial Activity of Cyadox against Pathogens Collected from Pigs, Chicken, and Fish in China. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33546407 | PubMed |
| 33182563 | Development of Resistance in Escherichia coli ATCC25922 under Exposure of Sub-Inhibitory Concentration of Olaquindox. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/33182563 | PubMed |
| 32877510 | Bacillus subtilis: a potential growth promoter in weaned pigs in comparison to carbadox. | J Anim Sci | 2020 | https://conductscience.org/library/papers/32877510 | PubMed |
| 28968083 | Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity. | J Med Chem | 2017 | https://conductscience.org/library/papers/28968083 | PubMed |
| 28858261 | Voltammetric Study of Some 3-Aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide Derivatives with Anti-Tumor Activities. | Molecules | 2017 | https://conductscience.org/library/papers/28858261 | PubMed |
| 28785420 | A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli. | Microb Genom | 2017 | https://conductscience.org/library/papers/28785420 | PubMed |
| 28018297 | Mechanisms of Antibacterial Action of Quinoxaline 1,4-di-N-oxides against Clostridium perfringens and Brachyspira hyodysenteriae. | Front Microbiol | 2016 | https://conductscience.org/library/papers/28018297 | PubMed |
| 27047380 | Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/27047380 | PubMed |
| 26296207 | Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli. | PLoS One | 2015 | https://conductscience.org/library/papers/26296207 | PubMed |
| 26087764 | Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents. | Curr Med Chem | 2015 | https://conductscience.org/library/papers/26087764 | PubMed |
| 18625764 | Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18625764 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/352264
GET https://conductscience.org/api/papers/v1/352264/references?page=2